✦ LIBER ✦

The Value of Pre-emptive Therapy for Cytomegalovirus after Liver Transplantation

✍ Scribed by V. Müller; A. Perrakis; J. Meyer; T. Förtsch; K. Korn; R.S. Croner; S. Yedibela; W. Hohenberger; V.S. Schellerer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial experience with oral valganciclo

✍ Clemens Aigner; Peter Jaksch; Guenther Winkler; Kriztina Czebe; Shahrokh Taghavi 📂 Article 📅 2005 🏛 Springer Vienna 🌐 English ⚖ 68 KB

Inital experience with oral valgancyclov

✍ C Aigner; P Jaksch; G Winkler; C Czebe; E Devyatko; S Taghavi; W Wisser; W Klepe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Pre-emptive Therapy for the Cytomegalovi

✍ Ji, W.; Kim, D.-S.; Jung, S.-W.; Yu, Y.-D.; Suh, S.-O. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Cidofovir as primary pre-emptive therapy

✍ Chakrabarti, S; Collingham, K E; Osman, H; Fegan, C D; Milligan, D W 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

Extended routine polymerase chain reacti

✍ Karl S. Peggs; Wolfgang Preiser; Panagiotis D. Kottaridis; Nikki McKeag; Nicola 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Risk-adapted pre-emptive therapy for cyt

✍ Mori, T; Okamoto, S; Matsuoka, S; Yajima, T; Wakui, M; Watanabe, R; Ishida, A; I 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 56 KB